Basic information Safety Supplier Related

2-bromolysergic acid diethylamide

Basic information Safety Supplier Related

2-bromolysergic acid diethylamide Basic information

Product Name:
2-bromolysergic acid diethylamide
Synonyms:
  • Ergoline-8-carboxaMide,2-broMo-9,10-didehydro-N,N-diethyl-6-Methyl-, (8b)-
  • 2-Bromo-LSD 2-Bromo-LSD
  • 2-bromo-lsd
  • Ergoline-8-carboxamide, 2-bromo-9,10-didehydro-N,N-diethyl-6-methyl-, (8β)-
  • 2-bromolysergic acid diethylamide
  • BOL-148
  • BromLSD
  • Bromlysergamide
CAS:
478-84-2
MF:
C20H24BrN3O
MW:
402.34
Mol File:
478-84-2.mol
More
Less

2-bromolysergic acid diethylamide Chemical Properties

Melting point:
120-127°
alpha 
D20 +15° (c = 0.5 in pyridine); D20 +53° (c = 0.5 in chloroform)
Density 
1.3040 (rough estimate)
refractive index 
1.6770 (estimate)
solubility 
DMSO: Soluble: =10 mg/ml
Ethanol: Soluble: =10 mg/ml
form 
Solid
Boiling point:
580.7±50.0 °C(Predicted)
pka
15.65±0.40(Predicted)
color 
Off-white to light yellow
More
Less

2-bromolysergic acid diethylamide Usage And Synthesis

Uses

2-Bromo-LSD (BOL-148; Bromolysergide) is a Dopamine Receptor antagonist that directly affects dopamine neurons in the substantia nigra neostriatum. 2-Bromo-LSD increases the hydroxylation of tyrosine in striatum and antagonizes the decrease of Apomorphine-induced DOPA accumulation. 2-Bromo-LSD also blocks the 5-HT Receptor mediated DOPA formation[1].

Safety Profile

Poison by intraperitoneal and intravenous routes. Experimental teratogenic and reproductive effects. Human systemic effects by ingestion: ddation of the arteries or veins. Many lysergic acid derivatives have central nervous system effects. When heated to decomposition it emits very toxic fumes such as Brand NOx. See other lysergic acid derivatives.

in vivo

2-Bromo-LSD (0.125-5.5mg/kg; i.p.; single dose) increases the in vivo tyrosine hydroxylation in the striatum of Male Sprague-Dawley rats, and increase the accumulation of DOPA with minimum effect dose of 0.125 mg/kg[1].

References

[1] Persson SA. The effect of LSD and 2-bromo LSD on the striatal DOPA accumulation after decarboxylase inhibition in rats. Eur J Pharmacol. 1977 May 1;43(1):73-83. DOI:10.1016/0014-2999(77)90162-5
[2] PAUL CARVEY . LSD and other related hallucinogens elicit myoclonic jumping behavior in the guinea pig[J]. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 1989, 13 1: Pages 199-210. DOI: 10.1016/0278-5846(89)90017-1
[3] WACHEŁKO O, NOWAK K, TUSIEWICZ K, et al. A highly sensitive UHPLC-MS/MS method for determining 15 designer LSD analogs in biological samples with application to stability studies†[J]. Analyst, 2024, 2: 290-308. DOI: 10.1039/d4an01361a

2-bromolysergic acid diethylamideSupplier

Chizhou Kailong Import and Export Trade Co., Ltd.
Tel
Email
xg01_gj@163.com
TargetMol Chemicals Inc.
Tel
+1-781-999-5354; +17819995354
Email
marketing@targetmol.com
Shanghai Jiegu Biotechnology Co., Ltd.
Tel
021-51698675
Email
sales@jiejiegroup.com
Cayman Chemical Company
Tel
800-364-9897
Email
sales@caymanchem.com
Hubei Yangxin Medical Technology Co., Ltd.
Tel
0714-3299675 13092790750
Email
3003355938@qq.com
More
Less

2-bromolysergic acid diethylamide(478-84-2)Related Product Information